The first and only FDA-approved CAR T treatment for people with mantle cell lymphoma (MCL)
whose prior treatment either didn't work or stopped working

patient image

TECARTUS™ is a treatment for your mantle cell lymphoma. It is used following disease progression while on or after other treatment. TECARTUS is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.